Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

170.02
-0.5700-0.33%
Volume:2.34M
Turnover:398.45M
Market Cap:409.47B
PE:18.21
High:171.48
Open:171.48
Low:169.96
Close:170.59
Loading ...

Johnson & Johnson Stock (JNJ) Bulls Target Breakout Despite Looming Patent Cliff

TIPRANKS
·
22 Jul

AstraZeneca unveils $50 billion US investment as pharma tariff threat looms

Reuters
·
22 Jul

Protagonist Therapeutics, Johnson & Johnson submit icotrokinra NDA to FDA

TIPRANKS
·
21 Jul

Johnson & Johnson Submits New Drug Application to FDA for First Approval of Icotrokinra, Aiming to Transform Plaque Psoriasis Treatment

Reuters
·
21 Jul

Daiwa Securities Adjusts Price Target on Johnson & Johnson to $170 From $150, Maintains Neutral Rating

MT Newswires Live
·
21 Jul

Ethereum Soars 80% in One Month — Breaks $3,800 Ahead of 10-Year Anniversary

TradingKey
·
21 Jul

10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever

Motley Fool
·
20 Jul

Major Stock Moves: J&J, Costco, Strategy, Snap, Citigroup

TIPRANKS
·
19 Jul

Top Executive Sells Millions in Johnson & Johnson Stock!

TIPRANKS
·
19 Jul

3 ASX ETFs for beginners (and experts) to buy and forget

MotleyFool
·
19 Jul

BUZZ-US stocks weekly: Tightrope

Reuters
·
19 Jul

John C. Reed, EVP of Innovative Medicine R&D, Reports Disposal of Johnson & Johnson Common Shares

Reuters
·
19 Jul

Johnson & Johnson Releases Transcript of Second-Quarter 2025 Earnings Call

Reuters
·
19 Jul

Johnson & Johnson Reports 4.1% Increase in Customer Sales, Net Earnings Per Share Decline by 1.8% in Latest Fiscal Period

Reuters
·
19 Jul

HSBC Adjusts Johnson & Johnson Price Target to $188 From $180, Maintains Buy Rating

MT Newswires Live
·
18 Jul

J & J Snack Foods (JJSF) Receives a Hold from Jefferies

TIPRANKS
·
18 Jul

Kenvue Inc. Unveils Groundbreaking Clinical Studies on Oral and Skin Health, Highlighting Innovative Solutions for Diabetes Patients and Newborn Care

Reuters
·
18 Jul

Johnson & Johnson's Q2 Beat Seen as 'Encouraging' Against Current Macro Backdrop, RBC Says

MT Newswires Live
·
17 Jul

BUZZ-Abbott falls after Q3 profit forecast disappoints investors

Reuters
·
17 Jul

Argus Research Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

TIPRANKS
·
17 Jul